“…; 32/368 (7%) | NTCP LKB model of incontinence with anal wall dose. Parameters found were n = 7.48; TD50 = 105; m = 0.46 | 1,3,4,5,6,7 (n/a: 2) | 1,3 | Smeenk [ 26 ] | Anal sphincter muscles | Individual muscles defined (Internal anal sphincter (IAS), external anal sphincter (EAS), puborectalis & levator ani) | Frequency, Urgency, Incontinence | 21/48 (44%) | For complication <5% Dmean<30Gy to IAS; <10Gy to EAS, < 50Gy to puborectalis, <40Gy to levator ani | 1, 4,5 (n/a 2) | 1,2,3 |
Smeenk [ 22 ] | Anal wall | Continuation of rectal wall from anal verge to slice below lowest slice with a rectal balloon | Frequency, urgency, incontinence | 39% frequency, 31% urgency, 31% incontinence | For urgency: Anal wall Dmean<38Gy risk < 15%, >38Gy risk is 62% | 1,4,7 (n/a 2,3,5,6) | 1,3 |
Lind [ 12 ] | Anal sphincter region | Inner muscle layer of the sphincter up to anal verge | Defecation into clothing without warning > 1 in last 6 months | 63/519 (12.1%) | Mean dose>50Gy to small bowel or sigmoid or anal sphincter region associated with this symptom (findings for individual organs not clarified) | 1, 7 (n/a 2,3) | 1,2,3 |
Yeoh [ 24 ] | Anal wall | From anorectal junction (not clearly defined) | LENT-SOMA total score | 72% | Anal wall V40 > 65% associated with chronic toxicity. | 1,5 (n/a 2,3) | 2,3 |
Thor [ 29 ] | Anal sphincter | Anal canal, inner and outer sphincter (not clearly defined) | Questionnaire of 19 questions in 4 domains: pain urgency, mucus & incontinence. |
…”